MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma

Applied Radiation and Isotopes

Volumn 61, Issue 5, 2004, Pages 887-891

  Chen, J C ^a   Chang, S M ^a   Hsu, F Y ^b   Wang, H E ^a   Liu, R S ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

Author keywords

4 borono 2 18F fluoro L phenylalanine fructose; Boron neutron capture therapy; Boronophenylalanine fructose (BPA F); F98 glioma; MicroPET

Indexed keywords

BORON COMPOUNDS; IRRADIATION; MATHEMATICAL MODELS; MEDICAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RATE CONSTANTS; TUMORS;

ARTERIAL BLOOD SAMPLING; BORON NEUTRON CAPTURE THERAPY (BNCT);

PHARMACOKINETICS;

4 BORONO 2 FLUOROPHENYLALANINE FRUCTOSE F 18; 4 BORONOPHENYLALANINE; 4 BORONOPHENYLALANINE FRUCTOSE; BORON DERIVATIVE; ORGANOBORON DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; BLOOD SAMPLING; BRAIN TUMOR; CONFERENCE PAPER; GLIOMA; IRRADIATION; ISOTOPE LABELING; MALE; NEUTRON CAPTURE THERAPY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

ANIMALS; BORON COMPOUNDS; BRAIN NEOPLASMS; FLUORINE RADIOISOTOPES; FRUCTOSE; GLIOMA; HUMANS; MALE; PHENYLALANINE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, INBRED F344;

EID: 4143088290     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.05.056     Document Type: Conference Paper

References (14)

1. Chandra S., Kabalka G.W., Lorey D.R. 2nd, Smith D.R., Coderre J.A. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy. Clin. Cancer Res. 8(8):2002;2675-2683
2. Coderre J.A. A phase I biodistribution study of p-boronophenylalanine. Gabel D., Moss R. Boron Neutron Capture Therapy: Toward Clinical Trials of Glioma Treatment. 1993;111-121 Plenum Press, New York
3. Diaz A.Z. Assessment of the results from the phase I/II boron neutron capture therapy trials at the brookhaven national laboratory from a clinician's point of view. J. Neurooncol. 62:2003;101-109
4. Hatanaka H., Nakagawa Y. Clinical results of long surviving brain tumor patients who underwent boron neutron capture therapy. Inst. J. Radiat. Oncol. Biol. Phys. 28:1994;1061-1066
5. Hideghety K., Sauerwein W., Haselsberger K., et al. Postoperative treatment of glioblastoma with BNCT at the Petten irradiation facility. Strahlenther Onkol. 175(suppl 2):1999;111-114
6. Imahori Y., Ueda S., Ohmori Y., et al. Fluorine-18-labeled fluroboronophenylalanine pet in patients with glioma. J. Nucl. Med. 39:1998;325-333
7. Imahori Y., Ueda S., Ohmori Y., et al. Positron emission tomography-based boron neutron capture therapy using Boronophenylalanine for high-grade gliomas: Part I. Clin. Cancer Res. 4:1998;1825-1832
8. 18F]fluoro-L-phenylalanine. Melanoma Res. 2:1992;171-179
9. Locher G.L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol Radium Ther. 36:1936;1-13
10. Slatkin D.N. A history of boron neutron capture therapy of brain tumors. postulation of a brain radiation dose tolerance limit Brain. 114:1991;1609-1629
11. Soloway A.H., Tjarks W., Barnum B.A., et al. The chemistry of neutron capture therapy. Chem. Rev. 98:1998;1515-1562
12. Takahashi Y., Imahori Y., Mineura K. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas. Clin. Cancer Res. 9(16 Pt 1):2003;5888-5895
13. 18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in glioma-bearing rat model. J. Nucl. Med. 45:2004;302-308
14. Yoshino K., Susuki A., Mori Y., et al. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Strahlenther Onkol. 165:1989;127-129